Literature DB >> 1417800

Truncation of N-terminal extracellular or C-terminal intracellular domains of human ETA receptor abrogated the binding activity to ET-1.

K Hashido1, T Gamou, M Adachi, H Tabuchi, T Watanabe, Y Furuichi, C Miyamoto.   

Abstract

We have investigated the function of N-terminal and C-terminal domains of the human ETA receptor by expressing truncated mutants in COS-7 cells. Three kinds of ETA receptors truncated in the N-terminal extracellular or C-terminal intracellular domains were produced. Deletion of the entire extracellular N-terminal or intracellular C-terminal domain completely inactivated the ET-1 binding activity. However, the deletion of one half of the N-terminal extracellular domain of the ETA receptor, missing one of two N-linked glycosylation sites, maintained complete binding activity. Specific monoclonal antibodies detected all the truncated ETA receptors in the cell membrane fraction of transfected COS-7 cells. The size of the ETA receptor was heterogeneous due to differential glycosylation and distributed in 48K, 45K and 42K dalton bands in Western blot analysis. These results demonstrated that a part of the N-terminal domain in close proximity to the first transmembrane region is required for the ligand binding activity of the ETA receptor, and the C-terminal domain is perhaps necessary as an anchor for maintenance of the binding site.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417800     DOI: 10.1016/0006-291x(92)90436-o

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Molecular characterization of a dual endothelin-1/Angiotensin II receptor.

Authors:  N Ruiz-Opazo; K Hirayama; K Akimoto; V L Herrera
Journal:  Mol Med       Date:  1998-02       Impact factor: 6.354

2.  Transcriptional regulation during development of the ductus arteriosus.

Authors:  Kathryn N Ivey; David Sutcliffe; James Richardson; Ronald I Clyman; Joseph A Garcia; Deepak Srivastava
Journal:  Circ Res       Date:  2008-07-17       Impact factor: 17.367

Review 3.  Endothelin.

Authors:  Anthony P Davenport; Kelly A Hyndman; Neeraj Dhaun; Christopher Southan; Donald E Kohan; Jennifer S Pollock; David M Pollock; David J Webb; Janet J Maguire
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.